Primary vaginal Ewing’s sarcoma/primitive neuroectodermal tumour: diagnostic and treatment challenges by Pranabandhu Das et al.
145
INTRODUCTION
Primitive neuroectodermal tumour (PNET) and
Ewing’s sarcoma suggest a single group of bone
and soft-tissue neoplasms in which typical
undifferentiated Ewing’s sarcoma and PNET
with clear  evidence of  neuroectodermal
differentiation morphologically represents both
ends of the spectrum.1 PNET of the female
genital tract is very unusual, but has been
reported  to  involve the ovary, uterine corpus,
uterine cervix, and vulva.2-5 PNET and Ewing’s
sarcoma   were considered as distinctive
entitities in the past. However some recent
studies  have shown that the small round-cell
tumours seen in both tumour types share
common phenotypic and molecular features
supporting  the likelihood  of a  common
progenitorship. Hence the term Ewing sarcoma
/PNET family  of tumours  is very  often
employed in the literature.1 Ewing’s sarcoma /
PNET are now defined as a group of small
round-cell sarcomas that show varying degrees
of neuroectodermal differentiation. Ewing’s
sarcomas refer to those neoplasms that lack
evidence of neuroectodermal differentiation
when  assessed  by  light  microscopy,
immunohistochemistry, and electron micros-
copy where as PNET tumours show neuro-
ectodermal features when assessed by one or
more of the above investigation modalities.2,3
This condition has rarely been described in the
literature and Ewing’s sarcoma/PNET of the
vagina is even rarer.
CASE REPORT
We present the case of a 50-year-old post-
menopausal lady with complaints of irregular
vaginal bleeding for the last two years. She also
had the history of difficulty in passing urine at
initiation of micturition of two months duration.
Clinical examination of vagina showed a hard,
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smooth indurated mass lesion in anterior
vaginal wall extending upto lower-third of the
vagina. All fornices were free and the uterus
and cervix appeared to be normal. Rectal
mucosa and bilateral parametria appears free
on  digital  rectal  examination.  Routine
haemogram, renal and liver function tests were
within normal limits. Chest radiograph revealed
no  abnormality  and  contrast-enhanced
computed tomography (CECT) thorax revealed
sub-centimeter sized  nodule in subpleural
location. Bilateral lung parenchyma, pleural
spaces, heart, great vessels, bilateral bronchi
were normal. CECT abdomen revealed both
right and left kidneys with pressure changes and
minimally dilated ureters, other organs and
biliary  tree were  normal; no  abdominal
lymphadenopathy was evident. Pelvic CECT
scan showed a moderately defined hetero-
geneously enhanced mass lesion measuring 7.0
 3.4  6.3 cm that involved anterior vaginal
wall showing  mass effect on urethra. Fat planes
were not clearly maintained with urethra and
bladder. Endometrial fluid collection and
evidence of right fundal fibroid were evident.
The mass was seen extending up to the introitus
along anterior vaginal wall thereby the urinary
bladder was pushed anteriorly towards the right
side. Bilateral adnexae were normal with no
ascites or lymphadenopathy (Figure 1). Punch
biopsy of the vaginal mass was then performed
which  showed multiple polypoidal bits of
tissue lined by  stratified squamous epithelium.
Sub-epithelium showed dilated blood vessels
with sheets of malignant round cells, often in a
perivascular location (Figure 2A). No definite
rosette formation was visible. These cells were
seen to encroach right upto the epidermis
however epidermotropism was not seen.
Mitotic rate was high. Focal necrosis was seen.
A diagnosis of malignant round cell tumour was
made with the following differential diagnsoses
such as embryonal rhabdomyosarcoma, non-
Hodgkin’s lymphoma and PNET/Ewing’s
sarcoma. The cells showed intracytoplasmic
periodic acid-schiff (PAS) positivity suggestive
of presence  of glycogen.  Immunohisto-
chemistry was done with a panel of antibodies,
which  revealed strong positivity for CD99
(Figure 2B) and vimentin and negativity for
cytokeratin (Figure 2C), epithelial membrane
antigen, desmin, leucocyte common antigen,
chromogranin. S-100 protein and neuron
specific enolase, suggestive of PNET / Ewing’s
sarcoma /PNET of anterior vaginal wall. Bone
marrow trephine biopsy showed normocellular
marrow with no evidence of tumour infiltration.
She was subjected to 3 cycles combination
chemotherapy  with vincristine (1.5 mg/m2),
doxorubicin (60 mg/m2) and cyclophosphamide
(600 mg/m2) given 3 weekly alternate with
ifosfamide (1800mg/m2) with  mesna  and
etoposide (100mg/m2) (VAC/IE). The induction
phase was followed by local treatment with
external beam radiotherapy (EBRT) to a total
dose of 50 Gray in 25 fractions over a period
of 5 weeks after which she was found to be
clinico-radiologically free of the disease.
Following this she received three cycles of
maintenance chemotherapy using the above
mentioned drugs. She is presently free of
disease and asymptomatic at 24 months after
diagnosis  of  disease.  Details  of  earlier
published cases on this subject are shown in
Table 1.1-10
Figure 1: Contrast enhanced computed tomography of
pelvis (axial view) showing large heterogenous mass
lesion in anterior vaginal wall displacing urinary bladder
anteriorly
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cases1-10 of PNET of vagina have previously
been reported in English language in journals
indexed in Medline.
Extraosseous Ewing sarcomas can arise in the
soft tissues of the chest wall, extremities,
paravertebral and retroperitoneal regions,
abdomen and pelvis, visceral organs,skin, head
and neck,4,5 but infrequently occur in the female
genital tract (Table 1). The diagnosis of Ewing’s
sarcoma Vs PNET is based on histologic,
immunohistochemical and molecular cyto-
genetic features. Uniform small round cells
with round nuclei containing fine chromatin,
clear or scanty eosinophilic cytoplasm with
glycogen content, and indistinct cytoplasmic
membranes are common microscopic features
of Ewing‘s sarcomas. In cases of PNET, the
tumours comprise small to medium sized cells
with moderate amounts of cytoplasm, variable
glycogen content, and variable degrees of
neuroectodermal differentiation.1 Immuno-
histochemical markers currently employed in
the diagnosis of Ewing‘s sarcoma /PNET
family  of  tumours  include  MIC2  (also
designated CD99), synaptophysin, S-100,
neuron-specific enolase, vimentin, and HBA-
71.1,6,7 CD99  is  mainly expressed  in  the
membranes  of  almost all  Ewing’s  sarcoma /
PNET tumours microneme protein-2 (MIC2)
expression is a highly sensitive and reliable
marker for the diagnosis of Ewing’s sarcoma /
PNET when  used as  part of  a panel  of
immunohistochemical marker antibodies,
inspite of the lack of complete specificity.1,8,9
The diagnosis in our patient was revised from
undifferentiated malignant round cell tumour
to Ewing‘s sarcoma/PNET  based on the results
of immunohistochemical staining.Management
of Ewing‘s sarcoma/PNET of vagina remains
controversial due to its rarity of presentation.
On literature review1-10 only one of ten reported
cases of primary vaginal Ewing‘s sarcoma/
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Figure 2A: Photomicrograph showing perivascular
location of round tumour cells with hyperchromatic
nucleis and scant cytoplasm (Haematoxylin and eosin,
 400)
Figure 2C: Photomicrography exhibiting cytokeratin
negativity  in  tumour  cells  on  immunohistochemistry
( 200)
Figure 2B:  microphotograph  exhibiting  strong
cytoplasmic positivity of tumour cell for MIC 2 (CD99)
on immunohistochemistry ( 200)
DISCUSSION
A Medline search using key word (tumour,
primitive neuroectodermal, Ewing’s sarcoma,
vaginal neoplasm)  revealed  that only ten148
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PNET presented with cranial metastasis 13
months after initial treatment of vaginal PNET,
multiple modalities of treatment like surgery
in the form of wide excision or hysterectomy
with bilateral salpingo-opherectomy, chemo-
therapy and local radiotherapy have been
employed.1-10 Out of ten documented cases so
far,1-10 three cases were offered chemotherapy
and EBRT with intracavitary brachytherapy had
favorable outcome whereas one case using both
induction and maintenance chemotherapy with
local radiotherapy reported good clinical
response to treatment (Table 1). The 5-year
disease-free survival is 24%-80% for localized
disease3 with smaller resectable lesions i.e, the
reported cases with vaginal location had a better
prognosis than other relatively common sites
of genital tract PNETs, namely, uterus, ovary,
cervix and vulva.
This case is being reported for its rarity of
presentation, emphasizing  the utililty of
immunohistochemical staining in establishing
the diagnosis of tumours at unusual sites.
Further the case also highlights the utility of
induction chemotherapy followed by radiation
treatment  and  subsequent  maintenance
chemotherapy as a treatment modality.
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